Genmab/Roche Announce Broad Antibody Development Collaboration Genmab A/S (CSE: GEN and Neuer Markt: GE9D), Copenhagen, Denmark, has announced a broad collaboration with Roche for the creation and development of human antibody therapeutic products for life threatening and debilitating diseases. Roche will have access to Genmab’s antibody development capabilities, as well as its pre-clinical and clinical […]
Category: Worldwide Biotech
Organon Gets First European Marketing Approval For Remeron CIMA LABS INC. (Nasdaq:CIMA), Eden Prairie, Minn., has announced that its pharmaceutical partner, Organon, has received its first European marketing approval for Remeron(R) SolTab(TM) from the Dutch Medicines Evaluation Board. The Dutch regulatory approval triggers a mutual recognition procedure involving other European countries. Remeron SolTab, an antidepressant […]
Cytogenix Patent Portfolio Grows And Goes International – Brief Article CytoGenix Inc. (CYGX), Houston, Texas, has received notification of the publication of international patent applications in its portfolio of antisense molecule expression technology. In addition to the parent patent of the original version of the company’s proprietary TroVec(TM) ssDNA intracellular expression vector, the international patents […]
Questcor Expands Emitasol License With Ahn-Gook Questcor Pharmaceuticals, Inc. (AMEX:QSC), Union City, Calif., has expanded its license agreement with Ahn-Gook Pharmaceutical Co., Ltd headquartered in Seoul, Republic of Korea, and has granted them the right to market Emitasol(TM), metaclopromide nasal spray, in 12 additional countries in Asia. Questcor will receive an upfront payment and will […]
Seracare To Distribute Grifols’ Human Serum Albumin In U.S SeraCare Life Sciences, Inc. (OTCBB: SRLS), Oceanside, Calif., a manufacturer and distributor of plasma-based diagnostic and therapeutic products and proteins for the biotech industry, has been named distributor of Grifols’ Human Serum Albumin (HSA) product for biotechnology and pharmaceutical companies in the United States. The HSA […]
Pel-Freez Gets Canadian Medical Device License For Ss Unitray Pel-Freez Clinical Systems, LLC has announced that the complete SSP UniTray(R) product line, which includes low and high resolution HLA typing kits, has received a Canadian Medical Device License. This license allows uninterrupted sales and service of products to Canada and is an indication of the […]
Astellas’ Screening Triggers Milestone Payment To Metabolex Metabolex, Inc., Hayward, Calif., a biotechnology company dedicated to the discovery and development of novel therapeutics for diabetes and related metabolic disorders, announced today that Astellas Pharma Inc. has begun high- throughput screening against another target from Metabolex’s proprietary database of human genes associated with insulin resistance and […]
Vertex/Mitsubishi To Develop Hcv Oral Protease Inhibitor Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX), Cambridge, Mass., and Mitsubishi Pharma Corporation have signed an agreement to develop and commercialize VX-950, Vertex’s investigational oral protease inhibitor for the treatment of hepatitis C virus (HCV) infection, in Japan and certain Far East countries. As part of the agreement, Mitsubishi will […]
Cepheid Names Izasa As European Distributor Of Smart Cycler Cepheid (Nasdaq: CPHD), Sunnyvale, Calif., has signed a multi-year distribution agreement with Izasa SA to market the Cepheid Smart Cycler(R) system, accessories, and disposable reaction tubes in the life sciences market in Spain, Portugal, Italy, Austria, France, the Netherlands and the United Kingdom. Izasa will provide […]
Avelox, Fast-Acting Antibiotic, Approved In Canada Bayer Inc. has announced Health Canada’s approval of Avelox(R) (moxifloxacin hydrochloride), a new antibiotic designed to rapidly treat patients suffering with common respiratory tract infections (RTIs). RTIs – which accounted for 10 million Canadian prescriptions in 1999, or 60 percent of all antibiotic prescriptions – including non-hospitalized pneumonia, bronchitis […]